Partner Publications



AfA Health Professional Newsletter

Aid for AIDS (AfA) was launched in May 1998 as a private sector HIV Disease Management programme providing a focused range of clinical interventions coupled with credible clinical support and on-going adherence management and patient support. The aim of the programme was to partner with healthcare providers and healthcare funders to optimize clinical outcomes by ensuring access to effective therapy and regular monitoring of outcomes and potential toxicity, thus limiting the frequency of treatment failure due to poor adherence or adverse effects. Sustained viral load suppression and immune recovery would reduce the risk of opportunistic infections and lead to improved survival. The programme has been successful and over 100,000 patients are currently receiving antiretroviral therapy with excellent clinical outcomes.

The AfA Clinical team can be contacted on 0800 227 700 or by email at afa@afadm.co.za. Further information about AfA, the current treatment guidelines and back-copies of the quarterly newsletters can be found on the AfA website.

 

TB South

Published by i-base, a London-based treatment activitist organisation, the HIV Treatment Bulletin is a not-for-profit community journal that reviews the most important advances in the clinical management of HIV and access to treatment. HTB-South is focused on Southern Africa and disseminated through the Society.

 





  • Issue 44
    01 Oct 2016

    Rifabutin dosing with protease inhibitors; Drug-drug interactions involving second generation NNRTIs; Pure Red Cell Aplasia in HIV


  • Issue 43
    01 Jun 2016

    Dolutegravir: its use in adult patients Dolutegravir: its use in paediatric patients Drug-drug interactions between antiretrovirals and itraconazole Zika and HIV


  • Issue 42
    01 Feb 2016

    Do elite controllers need ART? Early infant diagnosis of HIV - shifting paradigms Lifelong ART should be offered to ALL HIV-infected patients regardless of CD4 count Pneumococcal vaccination in HIV-infected persons


  • Issue 41
    01 Sep 2015

    Probiotics and HIV Improved treatment outcomes in patients with XDR TB in South Africa HIV tests in children on ART Management of hyperlipidaemia in patients on protease inhibitors Cross-reactivity between darunavir and co-trimoxazole New 0199 tariff claiming process


  • Issue 40
    01 Jul 2015

    Rilpivirine (RPV) in pregnancy Is there a need for 6-monthly CD4 monitoring in patients with stable virological suppression on ART? Twitter for the busy Clinician - Opening up a world of HIV-related information The role of micronutrient supplementation in adults


  • Issue 39
    01 Mar 2015

    HIV-positive-to-HIV-positive renal transplantation Pre-exposure prophylaxis (PrEP): recent findings add to the evidence that it is effective as an HIV prevention tool Use of raltegravir in children Balancing risks and benefits in post exposure prophylaxis


  • Issue 38
    01 Nov 2014

    Abacavir-based regimens in patients with high viral loads Proton pump inhibitor, H2 receptor blocker and antacid drug interactions with atazanavir/ritonavir Update on the Mississippi child - a reality check Maraviroc A festive reflection


  • Issue 37
    01 Aug 2014

    The EARNEST trial: new evidence regarding efficacy of second line ART regimens New drug profile: rilpivirine The value of a psychological report in treatment failure Clinical Case Report - 35 year old male patient on a PMB Medical Scheme Option (Subject to State Protocols)


  • Vol 6 No 4
    02 Dec 2013

    HTB South


  • HIV and your quality of life: guide to side effects and better long term health.
    14 Oct 2016

    This booklet now focuses as much on getting the best quality of life as it does on side effects.


  • Introduction to ART
    13 Oct 2016

    This booklet is a guide for anyone interested in HIV treatment. It is especially for HIV positive people to feel more in control of this part of life. The guide was written and reviewed by HIV positive people, activists and health professionals. Information is based on the 2016 update to the UK guidelines and the pill chart include all newly approved drugs.


  • Illustrated ARV pill chart
    13 Oct 2016

    September 2016


  • Vol 17, number 9/10
    05 Oct 2016

    September / October 2016 - HTB


  • Vol 17, number 7/8
    01 Aug 2016

    July / August 2016 - HTB


  • Vol 17, number 5/6
    01 Jun 2016

    May / June 2016 - HTB


  • Vol 17, number 3/4
    01 Apr 2016

    March / April 2016 - HTB


  • Vol 17, number 1/2
    01 Feb 2016

    January / February 2016 - HTB


  • Vol 16, number 11/12
    01 Dec 2015

    November / December 2015 - HTB


  • Vol 16, number 9/10
    01 Oct 2015

    September / October 2015 - HTB


  • Vol 16, number 7/8
    01 Aug 2015

    July / August 2015 - HTB


  • Vol 16, number 5/6
    01 Jun 2015

    May / June 2015 - HTB


  • Vol 16, number 3/4
    01 Apr 2015

    March / April 2015 - HTB


  • Vol 16, number 1/2
    01 Feb 2015

    January / February 2015 - HTB


  • Vol 7 No 4
    24 Nov 2014

    HTB South,


  • The 2014 Pipeline Report
    22 Jul 2014

    The 2014 Pipeline report, co-authored by i-base and TAG, covers HIV, HCV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure and immune-based and gene therapies in development


  • Vol 7 No 3
    07 Jul 2014

    HTB South


  • Vol 7 No 2
    07 Apr 2014

    HTB South


  • Vol 7 No 1
    27 Jan 2014

    HTB South


  • Vol 6 No 3
    03 Sep 2013

    HTB South


  • 2013 Pipeline Report
    03 Jul 2013

    The 2013 Pipeline report, co-authored by HIV i-base and TAG, covers HIV, HCV and TB drugs, diagnostics, vaccines, preventive technologies, research toward a cure and immune-based and gene therapies in development


  • Vol 6 No 2
    01 Apr 2013

    HTB South


  • Vol 6 No 1
    29 Jan 2013

    HTB South


  • Vol 5 No 4
    26 Nov 2012

    HTB South


  • HIV, HCV, TB: 2012 Pipeline Report, TAG and i-base
    23 Jul 2012

    The annual i-Base/TAG pipeline report, which covers research into drugs and diagnostic tests that are the most advanced in development


  • Vol 5 No 3
    06 Jul 2012

    HTB South


  • Vol 5 No 2
    01 Jun 2012

    HTB South


  • Vol 5 No 1
    18 Apr 2012

    HTB South: Conference coverage includes a meeting on HIV and women’s health, another on HIV persistence and cure research, as well as the European AIDS Conference and ICAAC.


  • Vol 4 No 4
    01 Dec 2011

    HTB South: Includes final reports from IAS 2011 looking at the latest in cure research, ART and TB, and reassuring circumcision results from Orange Farm that dispel concerns about risk compensation.


  • July - Sept 2011
    01 Sep 2011

    HTB South: This issue leads with the most important and exciting research from the IAS conference in Rome and the 3rd International Workshop on HIV Pediatrics immediately preceding it.


  • January - March 2011
    01 Jan 2011

    HTB South: 1st International Workshop on HIV and Women


  • April - June 2010
    01 Apr 2010

    HTB South: 16th Conference on Retroviruses and Opportunistic Infections


  • January - March 2010
    01 Jan 2010

    HTB South: 17th Conference on Retroviruses and Opportunistic Infections (CROI)


  • October - December 2009
    01 Oct 2009

    HTB South: 11th International Workshop on Adverse Drug Reactions and Co-morbidities in HIV (IWADR)


  • July - Sept 2009
    01 Jul 2009

    HTB South: i-Base Q&A: swine flu and HIV


  • April - June 2009
    01 Apr 2009

    HTB South: 16th Conference on Retroviruses and Opportunistic Infections (CROI)


  • January - March 2009
    01 Jan 2009

    HTB South: 16th Conference on Retroviruses and Opportunistic Infections


  • September - December 2008
    01 Sep 2008

    HTB South: OCTANE Trial DSMB finds ritonavirboosted lopinavir superior to nevirapine in HIV-positive women previously exposed to single dose nevirapine


  • January - August 2008
    01 Jan 2008

    HTB South: 38th World Conference on Lung Health of the Union against TB and Lung Disease



Copyrights ©2017: Southern African HIV Clinicians Society